New migraine prevention pill EVO756 enters Mid-Stage trial

NCT ID NCT07616128

First seen Jun 26, 2026 · Last updated Aug 11, 2026 · Updated 5 times

Summary

This Phase 2 study tests whether a daily pill called EVO756 can prevent migraines in adults who have not had success with other preventive treatments. About 330 participants will receive either EVO756 or a placebo, and researchers will track how many migraine days they have each month. The goal is to see if EVO756 safely reduces migraine frequency.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
EVO756 (daily oral pill)
What this could lead to
If it works, this could offer a new daily pill to prevent migraines for people who haven't had success with other treatments.
What could go wrong
This is an early Phase 2 trial with only 330 people, so results may not hold up in larger studies. The drug may not reduce migraines better than a placebo, and side effects are still being studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Accel Research Site-Decatur-Alcanza

    RECRUITING

    Decatur, Georgia, 30030, United States

  • Apple Medical Research Group, Inc

    RECRUITING

    Miami, Florida, 331216, United States

    Contact Email: •••••@•••••

  • Asheville Neurology Specialists, Pa

    RECRUITING

    Asheville, North Carolina, 28806, United States

  • Bio Behavoural health

    RECRUITING

    Toms River, New Jersey, 08755, United States

  • CA Medical Clinic for Headache

    RECRUITING

    Los Angeles, California, 90067, United States

  • Clinical Neuroscience Solutions, Inc.

    RECRUITING

    Jacksonville, Florida, 32256, United States

  • Clinical Neuroscience Solutions, Inc.

    RECRUITING

    Orlando, Florida, 32819, United States

    Contact Email: •••••@•••••

  • Clinical Trials of South Carolina

    RECRUITING

    Charleston, South Carolina, 29406, United States

    Contact Email: •••••@•••••

  • Clinosis - Dent Neurologic Instite

    RECRUITING

    Amherst, New York, 14226, United States

  • Diablo Clinical Research dba Flourish Research

    RECRUITING

    Walnut Creek, California, 94598, United States

  • Eximia Research NC

    RECRUITING

    Raleigh, North Carolina, 27607, United States

  • FutureSearch Trials of Dallas

    RECRUITING

    Dallas, Texas, 75251, United States

  • FutureSearch Trials of Neurology

    RECRUITING

    Austin, Texas, 78731, United States

    Contact Email: •••••@•••••

  • Michigan Headache and Neurological Institute

    RECRUITING

    Ann Arbor, Michigan, 48104, United States

  • Neuro Pain Research Center

    RECRUITING

    Fresno, California, 93710, United States

  • New England Institute for Neurology and Headache

    RECRUITING

    Stamford, Connecticut, 06905, United States

  • SFF Medical Research Group LLC

    RECRUITING

    Houston, Texas, 77018, United States

  • Trialsphere Corp

    RECRUITING

    Chandler, Arizona, 85286, United States

    Contact Email: •••••@•••••

  • Vantage Clinical Trials

    NOT_YET_RECRUITING

    Tampa, Florida, 33614, United States

  • Vaught Neurological Services

    RECRUITING

    Crab Orchard, West Virginia, 25827, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.